HBIO Dividend: Harvard Bioscience Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

HBIO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	87	94	112	113	118	102
Revenue Growth (YoY)	-10%	-16%	-1%	-4%	16%	-12%
Cost of Revenue	37	39	45	51	51	44
Gross Profit	49	54	66	62	67	58
Selling, General & Admin	37	43	46	48	47	43
Research & Development	8	10	11	12	10	8
Operating Expenses	51	60	64	67	64	57
Other Non Operating Income (Expenses)	-1	0	0	0	0	0
Pretax Income	-53	-11	-2	-9	0	-7
Income Tax Expense	0	0	0	0	0	0
Net Income	-53	-12	-3	-9	0	-7
Net Income Growth	279%	300%	-67%	--	-100%	75%
Shares Outstanding (Diluted)	44.55	43.53	42.42	41.4	40.3	38.6
Shares Change (YoY)	2%	3%	2%	3%	4%	2%
EPS (Diluted)	-1.22	-0.28	-0.08	-0.23	-0.01	-0.2
EPS Growth	272%	254%	-65%	2,200%	-95%	67%
Free Cash Flow	6	-1	11	0	0	8
Free Cash Flow Per Share	0.13	-0.02	0.25	0	0	0.2
Gross Margin	56.32%	57.44%	58.92%	54.86%	56.77%	56.86%
Operating Margin	-1.14%	-5.31%	1.78%	-3.53%	2.54%	0%
Profit Margin	-60.91%	-12.76%	-2.67%	-7.96%	0%	-6.86%
Free Cash Flow Margin	6.89%	-1.06%	9.82%	0%	0%	7.84%
EBITDA	3	0	7	2	8	5
EBITDA Margin	3.44%	0%	6.25%	1.76%	6.77%	4.9%
D&A For EBITDA	4	5	5	6	5	5
EBIT	-1	-5	2	-4	3	0
EBIT Margin	-1.14%	-5.31%	1.78%	-3.53%	2.54%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%